Skip to main content
Pharma and Healthcare

Case Study: Does Branding Impact Sales?

How OSG helped a global pharmaceutical company evaluate and prioritize potential scientific statements intended to launch an unbranded campaign to educate physicians before the launch of Drug X.

A global pharmaceutical company and its agency of record were planning to launch an unbranded campaign to shape the opioid-Induced nausea and vomiting (OINV) treatment market for the later launch of Drug X and thus wanted to test potential scientific statements that would boost this campaign. Using Dynamo, OSG’s AI-driven big data analytics platform, OSG conducted research in the United States to prioritize messages designed to launch a campaign that educates physicians about OINV and drives them to seek more information.

Check out more of our case studies:

Case Study: Personalized Marketing at Scale

How OSG helped a global pharmaceutical company carve out its messaging strategy for targeted impact without sacrificing reach.

Case Study: Optimizing Healthcare Costs

How OSG helped a global health insurer segment its customers, understand their lifetime value, and predict their engagement in the future, thereby establishing a product strategy for every customer segment.